Aderamastat (FP-025) is an orally active matrix metalloproteinase 12 (MMP-12) inhibitor. Aderamastat can be used for the research of asthma, chronic obstructive pulmonary disease (COPD), and pulmonary fibrosis.
References:
[1]. Li, Yuhua, et al. Safe administration of MMP-12 inhibitor. Patent. WO2022261624 A1.
















